Skip to content

Blog

Latest articles, insights, and updates from the blog.

178 articles

Have a question about this topic?

Use the contact page when you need to send feedback, request a correction, or ask about the resource.

News1 min read

Ketamine Side Effects Data: What TRD Patients Need to Know

New clinical analysis urges smarter ketamine protocols for TRD—what side effect data and dropout rates mean for patients exploring online ketamine treatment.

News1 min read

What New NMDA Data Means for Ketamine Patients

New clinical guidance on NMDA receptor antagonists urges smarter dose optimization and faster switching. Here's what it means for online ketamine patients.

News1 min read

NMDA Antagonists for TRD: What the Data Means for You

New clinical data on NMDA receptor antagonists for TRD highlights side effect profiles, dropout rates, and why faster dose optimization matters for patients.

News1 min read

When Clinicians Switch Sooner: New TRD Dosing Guidance

New clinical guidance urges faster dose adjustments and PHQ-9 tracking for ketamine patients. Here's what it means for your online treatment.

News1 min read

Faster TRD Remission: What Smarter Dosing Means for You

New clinical guidance on treatment-resistant depression highlights why symptom tracking and dose flexibility matter—especially for online ketamine patients.

News1 min read

What Side Effect Data Means for Ketamine Patients

New research in Psychiatric Times breaks down side effect profiles and dropout rates for ketamine and esketamine. Here's what it means for your treatment decision.

News1 min read

Nitrous Oxide for Depression: What Patients Should Know

New research explores nitrous oxide for treatment-resistant depression. Here's how it compares to ketamine and what it means for patients seeking relief in 2026.

News1 min read

What New TRD Data Means for Ketamine Patients

New clinical guidance on NMDA receptor antagonists urges faster dose optimization and closer monitoring. Here's what it means for online ketamine treatment.

News1 min read

Trump's Psychedelic EO: What It Means for Ketamine Patients

President Trump's 2026 executive order on psychedelic research signals new federal support for ketamine therapy. Here's what online patients need to know.

News1 min read

What Ketamine's Side Effect Data Means for You

New clinical guidance on NMDA antagonist side effects and discontinuation rates has direct implications for patients pursuing ketamine therapy online.

News1 min read

What New NMDA Data Means for Your Ketamine Care

New clinical guidance on ketamine and esketamine side effect tracking is reshaping how providers manage treatment-resistant depression. Here's what it means for you.

News1 min read

Glutamate Treatments Reshape TRD Care in 2026

New research confirms glutamate-based treatments like esketamine offer fast relief for treatment-resistant depression. Here's what it means for online ketamine care.